Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G
TM Welzel, WJ Miley, TL Parks, JJ Goedert… - Journal of clinical …, 2006 - Am Soc Microbiol
The detection and quantification of hepatitis B virus (HBV) DNA play an important role in
diagnosing and monitoring HBV infection as well as assessing therapeutic response. The …
diagnosing and monitoring HBV infection as well as assessing therapeutic response. The …
Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay
The VERSANT hepatitis B virus (HBV) 3.0 Assay (branched DNA [bDNA])(referred to herein
as VERSANT 3.0) was evaluated at four external sites for analytical sensitivity, specificity …
as VERSANT 3.0) was evaluated at four external sites for analytical sensitivity, specificity …
Comparison of currently available assays for detection of hepatitis B virus DNA in the routine diagnostic laboratory
HH Kessler - Expert Review of Molecular Diagnostics, 2005 - Taylor & Francis
Infection with the hepatitis B virus (HBV) continues to present diagnostic and therapeutic
challenges worldwide. Today, many routine diagnostic laboratories have implemented …
challenges worldwide. Today, many routine diagnostic laboratories have implemented …
Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification …
CY Dai, ML Yu, SC Chen, ZY Lin, MY Hsieh… - Journal of clinical …, 2004 - jcp.bmj.com
Aims: To evaluate the performance characteristics and clinical usefulness of the COBAS
Amplicor HBV monitor (COBAS-AM) test in Taiwan and to examine its correlation with the …
Amplicor HBV monitor (COBAS-AM) test in Taiwan and to examine its correlation with the …
Comparison of Versant HBV DNA 3.0 and COBAS AmpliPrep–COBAS TaqMan assays for hepatitis B DNA quantitation: Possible clinical implications
AR Garbuglia, C Angeletti, FN Lauria, P Zaccaro… - Journal of virological …, 2007 - Elsevier
We compared two commercial assays for HBV DNA quantitation, Versant HBV 3.0, System
340 (bDNA; Bayer Diagnostics) and COBAS AmpliPrep–COBAS TaqMan HBV Test …
340 (bDNA; Bayer Diagnostics) and COBAS AmpliPrep–COBAS TaqMan HBV Test …
循环无细胞DNA 检测及在肝病中的研究应用
陈恳， 张弘 - Medical Diagnosis, 2013 - hanspub.org
循环无细胞DNA 是一种无细胞状态的胞外DNA, 广泛存在于人体体液中. 近年来,
对循环无细胞DNA 的研究逐渐受到人们的重视, 越来越多的研究将循环无细胞DNA …
对循环无细胞DNA 的研究逐渐受到人们的重视, 越来越多的研究将循环无细胞DNA …
Slovene national guidelines for the prevention of hepatitis B reactivation in patients undergoing immunosuppressive therapy
M Matičič, M Poljak - Slovenian Medical Journal, 2010 - vestnik.szd.si
Chronic hepatitis B virus infection as well as the presence of a past viral infection may lead
to the reactivation of hepatitis B in patients undergoing immunosuppressive therapy due to …
to the reactivation of hepatitis B in patients undergoing immunosuppressive therapy due to …
[PDF][PDF] Multicenter Evaluation of the VERSANT
J Surtihadi, HJ Hnatyszyn, SYST Menting, L Merrick… - Citeseer
MATERIALS AND METHODS Testing facilities and samples. Evaluation of performance
characteristics of the VERSANT 3.0 and analysis of clinical specimens was performed by …
characteristics of the VERSANT 3.0 and analysis of clinical specimens was performed by …
Zdravljenje bolnikov s kroničnim hepatitisom bv Splošni bolnišnici Celje
G Lešničar - Slovenian Medical Journal, 2005 - vestnik.szd.si
Background: A third of world's population has serological evidence of a past or current
infection with hepatitis B virus and 350 million people have chronic infection. Chronic …
infection with hepatitis B virus and 350 million people have chronic infection. Chronic …